Vepdegestrant - CanMED: HCPCS

Return Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Vepdegestrant

Brand Name:

Veppanu

Strength:

100mg, 200mg

HCPCS:

N/A

SEER*Rx Category:

Hormonal Therapy

Major Drug Class:

Proteolysis Targeting Chimera (PROTAC)

Minor Drug Class:

ER, Cereblon/CRBN

Oral (Y/N):

Yes

FDA Approval Year:

2026

FDA Discontinuation Year:

CMS Effective Date:

CMS Discontinuation Date:

Status:

In Use